Nextage Therapeutics Ltd (NXTG) — Financial Flexibility Index

Latest as of June 2022: -0.97x

Nextage Therapeutics Ltd (NXTG) has a Financial Flexibility Index of -0.97x as of June 2022. Free cash flow of ILA-1.72 Million (operating CF ILA-1.72 Million minus capex ILA0.00) represents -1% of total liabilities (ILA1.77 Million). Check NXTG capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

-0.97x
Free Cash Flow / Total Liabilities

Free Cash Flow

ILA-1.72 Million
Operating CF − Capex

Total Liabilities

ILA1.77 Million
ILA

Capital Expenditures

ILA0.00
ILA

Nextage Therapeutics Ltd Financial Flexibility Index (2017–2024)

Historical Financial Flexibility Index trend for Nextage Therapeutics Ltd across 8 annual periods. See Nextage Therapeutics Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Nextage Therapeutics Ltd (2017–2024)

Year-by-year free cash flow to debt coverage for Nextage Therapeutics Ltd. For the full company profile including market capitalisation, see NXTG market cap.

Year Flexibility Index Free Cash Flow (ILA) Operating CF Total Liabilities YoY Change
2024 -0.13x ILA-795.00K ILA-795.00K ILA5.89 Million ▲ +77.1%
2023 -0.59x ILA-2.26 Million ILA-2.26 Million ILA3.83 Million ▲ +81.0%
2022 -3.10x ILA-6.01 Million ILA-6.01 Million ILA1.94 Million ▼ -193.0%
2021 -1.06x ILA-3.97 Million ILA-3.97 Million ILA3.76 Million ▲ +56.0%
2020 -2.40x ILA-6.30 Million ILA-6.31 Million ILA2.62 Million ▼ -94.5%
2019 -1.24x ILA-2.90 Million ILA-2.93 Million ILA2.35 Million ▼ -78.0%
2018 -0.69x ILA-4.95 Million ILA-4.95 Million ILA7.12 Million ▲ +2.4%
2017 -0.71x ILA-5.66 Million ILA-5.67 Million ILA7.96 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities